Redefining Neuroimaging for Therapeutic Innovation

At ZRO, we’re redefining how neuroimaging is done by combining scientific depth with operational speed to help our partners move faster from discovery to decision. We make imaging a strategic advantage, not a bottleneck.

Our team includes recognized scientific leaders with hands-on experience in PET and MRI for neurodegenerative diseases, bringing focus, precision, and accountability to every project.
We work closely with biopharma, diagnostics, and research consortia developing new therapies and biomarkers for neurodegenerative disease.

We don’t just support clinical programs; we move them forward.
ZRO stands for more than our name: zero delays, zero unnecessary complexity, and a future with zero neurodegenerative disease.